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Introduction
The success of clinical lung transplantation is poor when
compared with other organ transplants due to acute rejec-
tion. Acute lung rejection is accompanied by infiltration of
leukocytes into the alveolar, perivascular, peribronchial and
interstitial spaces of the transplanted lung, which increase in
severity with the advancement of the rejection processes1,2.
One of the commonly used methods to monitor alveolar infil-
tration of leukocytes is to analyze cells in the bronchoalveolar
lavage fluid (BALF)3. In contrast, histological analysis was
mainly used to study cells infiltrating the perivascular or
peribronchial spaces. These in situ studies showed infiltra-
tion of highly proliferative macrophages into the tissue of
lung allografts2. Histological study does not, however, nec-
essarily reflect the events that occur in the whole organ of
the lung. Unlike histological analysis, flow cytometric analy-
sis using single cell suspensions of infiltrating cells permits
quantitative analysis of infiltrating cells.
Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4)-
Ig was designed as a passive blocker of T cell activation by
binding to activated APCs therefore preventing intracellular
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MHC-mismatched lung allografts are rapidly rejected by the host immune response. We analyzed cells infiltrating the
grafted lung tissue using a collagenase-digestion method. The grafted lung was filled with host-derived leukocytes as early
as day 1 post transplantation and the majority of the initial infiltrating cells were granulocytes. This initial influx of granulocytes
waned rapidly, followed by a steady increase in lymphocytes, particularly T cells, and then by macrophages. The proportion
of CD4+ T cells that express CD25 were increased in the graft the majority of which were activated CD4+ cells. We applied
cytotoxic T-lymphocyte-associated antigen 4 (CTLA4)-Ig treatment in combination with donor-specific blood transfusion to the
transplantation of lung allograft, which was significantly prolonged by the treatment. To examine the cellular and molecular
basis of the inhibition of the graft rejection, we evaluated number and cytokine mRNA expression of the cells infiltrating in the
lung allograft using collagenase-digestion method, although we were unable to detect significant effects of the treatment.
Taken together, this study demonstrates that single cell suspensions from cellular infiltrates of lung tissue is useful for
phenotypical and functional studies on cells infiltrating lung tissue after graft transplantation.
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signaling through CD28 on T cells4. Studies showed that
the CTLA-4-Ig fusion protein dampens pathogenic T cell
responses in autoimmunity and transplantation models and
it has already entered into the clinical stage of development5, 6.
Successful treatment of lung allo-transplants with CTLA4-Ig
has been reported in a combination of Brown Norway (BN)
donor to F344 strain recipient that are incompatible with
major histocompatibility antigen complex (MHC) molecule,
RT17. In other combinations of donor (BN) and recipient
(Lewis), CTLA4-Ig alone had little effect, but in combina-
tion with sirolimus, a cell-cycle inhibitor, significant pro-
longation of graft survival was achieved8. Donor-specific
blood transfusion (DST) is another effective method to in-
duce inhibition of donor-specific immune responses9. The
combination of DST and CTLA4-Ig was, however, re-
ported not to be effective in inhibiting parameters of graft
rejection in BN to Lewis lung transplantation10, although
the method was effective in long term survival of cardiac
allografts11.
We applied a method of collagenase digestion to analyze
the population of cells infiltrating the perivascular or perialveolar
lung tissue using flow cytometry in the combination of BN
donor to Lewis recipient transplantation. In both BALF and
enzyme-digested lung tissue the waves of infiltration of the
different types of leukocytes, granulocytes and lymphocytes
into the graft were observed after lung transplantation. This
method allowed us to study the phenotype and cytokine ex-
pression profile of the purified CD4+ and CD8+ T cells that
infiltrate into the allograft.
Materials and Methods:
Animals
Brown Norway (BN)(RT1n) and Lewis (LEW)(RT1l) rats
weighing 200 to 300 g were purchased from Charles River
Japan, and were maintained in the Laboratory Animal Center
for Animal Research at Nagasaki University. Age and sex
matched rats were used at 8-12 wks of age. The animal ex-
periments reported herein were approved by the Institutional
Anima Care and Use Committee of Nagasaki University
and were conducted according to the guidelines for Animal
Experimentation, Nagasaki University.
Lung transplantation and DST
Orthotopic transplantation of the left lung was performed
in an RT1 incompatible combination from BN to LEW
using a cuff technique as described previously12. In brief,
donor animals were anesthetied, and medial sternotomy
was performed to expose the lungs. Recipient animals were
then anesthetized, a left thoracotomy was performed, and
the left lung was dissected and removed following clamp-
ing of the pulmonary artery, vein and left main bronchus.
All anastomoses were performed with cuff technique. Rats
with acute allograft dysfunction immediately following im-
plantation were judged technical failure and excluded from
further study. For DST, single cell suspension of donor spleen
cells were filtered through sterile gauze and suspended in
PRMI1640. After lysis of RBC, cells were washed three
times with PBS and were injected through the tail vein of
the recipient rat (4.0x107/rat). The rejection of the trans-
planted lung was judged by radiographic monitoring, and
the >80% radiographic opacification was considered to be
indicative of the rejection as described8.
Cell preparation and flow cytometry
BAL was performed by canulation of the trachea with a
14-gauge catheter secured by suture. PBS (9ml) was in-
stilled into the main-stem bronchus and aspirated. After
BAL, lungs were resected, avoiding lymph node tissues.
Lung tissues were minced with scissors and enzymatically
digested in RPMI1640 containing collagenase A (10 mg/ml)
at 37°C for 60 min. Cells were filtered through sterile mesh,
washed and resuspended in staining media.
The staining reagents used in this study include PE-anti-
CD4, FITC-anti-CD8, biotin-anti-CD25, biotin-anti-TCR,
biotin-anti-RT1A, streptavidin-APC and FITC-anti-RT1Aa,b, l
(BD Biosciences). 7-amino-actinomycin D was added to
exclude dead cells from the analysis. For analysis of foxp3
expression, cells were stained with FITC-CD4, biotin-anti-
CD25 plus streptavidin-APC, fixed, permeabilized and stained
using a foxp3 staining kit (eBiosciences). Samples were
analyzed using FACScan or FACSCanto II (BD Biosciences).
CTLA4-Ig
Complementary DNA for CTLA4-Ig protein was pre-
pared by PCR-amplification of the extracellular domains of
mouse CTLA-4 from CD25+ BALB/c spleen cells with
primers (5'-ATTCTCGAGCCAGCCATGGCTTGTCTTGG-
3' and 5'-CGGGATCCGCGTCAGAATCCGGGCATGGTT-
3') that allowed fragments to be digested with HindIII and
BamHI, and ligation in frame to a human Fc IgG2a cDNA
fragment encoded in a CDM8 expression vector as described
in Current Protocols in Immunology (Hollenbaugh and Aruffo,
2002). Culture supernatant was collected from COS cells
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that were transiently transfected with the CTLA4-Ig construct
using the DEAE-dextran method as described13. After con-
centration of the supernatant, CTLA4-Ig was purified using
a protein A column. Purification of CTLA4-Ig was confirmed
by SDS-PAGE on a 12% gel run under reducing conditions
and visualized by Coomassie brilliant blue staining.
Real-time PCR
Lung cell suspension was treated with biotin-anti-rat CD4
or biotin-anti-rat CD8 mAb, incubated with streptavidin-
IMag, and CD4+ or CD8+ cells were prepared using IMag
System, respectively (BD Biosciences). RNA was prepared
from cells using Isogen (Nippon gene) and real-time PCR
was performed as described previously14. Briefly, comple-
mentary DNA was generated from 2 g total RNA by using
random hexamers and was amplified by real-time PCR
using specific primers (Table 1) in the buffer containing
SYBER green. The mRNA expression was determined as
the ratio of each DNA to G3PDH.
Statistics
Data from the different groups were compared using one-
way analysis of variance (ANOVA) and examined by Scheffe'
multiple comparison test. A two-tailed P value < 0.05 was
considered significant. StatView Software, version 5.0 (SAS
institute, Inc., Cary, NC) was used for the statistical analysis.
Results
Waves of infiltrating host immune cells into the
grafted lung
Orthotopic left lung transplantation was performed in the
fully allogeneic BN to LEW rat strain combination. The
following day cells were recovered from BALF as well as
from the collagenase-digested grafted lung. Cell origin was
determined by staining with allele-specific anti-MHC class
I antibodies (Fig. 1A). Nearly 90% of the cells recovered
from the BALF and enzyme-digested lung were of the host
origin. To examine the characteristics of these infiltrating
cells in the transplanted lung, the numbers and phenotypes
of cells from BALF, lung and spleen were determined
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Table 1. Primer sequences used for real-time RT-PCR










Figure 1. Waves of infiltrating cells into the lung allograft.
(A) Cells were prepared from BALF and collagenase-digested left
lung tissue from BN (donor), Lewis (control) and Lewis trans-
planted with left lung of BN 1 day earlier (1POD). Cells were
stained with FITC-anti-RT1Aa,b,l and biotin-anti-RT1A plus
streptavidin-PE, and were analyzed using FACScanto II. The
numbers indicate the proportions of cells in each quadrant.
(B) Grafted lung tissue from Lewis transplanted with BN lung
was isolated 1, 3 and 5 days after transplantation (1,3, 5POD).
Control shows the profiles of Lewis left lung. Lungs were digested
with collagenase and the single cell suspension was stained with
the combinations of FITC-anti-rat granulocyte Ab (clone HIS48)
and PE-anti-rat macrophage (clone HIS36), FITC-anti-CD45R and
PE-anti-TCR. The gates were set as shown in the profiles of side
scatter (SSC) and forward scatter (FSC); macrophage/granulocytes
by large gate, and lymphocytes by smaller lymphocyte gate. Numbers
indicate the percentage of cells in each quadrant
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using flow cytometry on 1, 3, and 5 days after transplanta-
tion. The total cell number generally increased in BALF
and lung after transplantation, while the spleen cell number
was relatively stable (Fig. 2). We next examined the cell
types that were recruited during this period using cells re-
covered from the lung and BALF (Fig. 1B, Fig. 2). Flow
cytometric analysis of side scatter (SS) vs. forward scatter
(FSC) indicated an increase in granular cells on day 1 post
transplantation in the lung and BALF, which decreased af-
terwards on day 3 and 5. Cell surface staining with antibod-
ies clearly indicated that these cells infiltrating the lung tis-
sue on day 1 post transplantation were granulocytes (Fig.
1B). In contrast, the ratio of T cells was reduced on day 1
post transplantation, and the number gradually increased on
day 3 and 5 post transplantation. Macrophages (CD45R+
cells) gradually increased and reached a peak level on day
5 post transplantation in the BALF and lung. These changes
were not seen in the spleen. Therefore, the transplanted
lung was infiltrated by waves of different types of cells,
first by a transient increase in granulocytes, second by the
gradual increase in T lymphocytes, and by the small but
steady increase in macrophages.
We also examined the expression of CD25 and foxp3 in
CD4+ T cells, since CD25+foxp3+ T cells are regulatory T
cells, while CD25+foxp3- T cells are activated T cells. In
the lung, the proportions of CD25+foxp3+CD4+ T cells in-
creased on day 3 after transplantation when the number of
T cells increased in this organ. The proportion of CD25+
foxp3-CD4+ cells, however, increased on day 1 post trans
plantation (Fig. 3). Therefore, activated T cells were quickly
recruited to the lung followed by an increase in the number
of regulatory T cells.
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Figure 2. Number of cells recovered from BALF, lung tissue and
spleen of the recipient rat.
Cells were recovered from BALF, collagenase-digested lung
allograft and spleen from Lewis (control) and from Lewis 1, 3 and
5 days after transplantation (1, 3, 5). Total viable cell numbers
were counted under microscopy using trypan blue staining. Cells
were stained and analyzed using flow cytometry as shown in Fig.
1. The numbers of granulocytes (HIS48+ cells), macrophages
(HIS36+ cells), T cells (TCR+ cells) and B cells (CD45R+ cells)
were determined by multiplying the total cell number with the
ratio of each cell type obtained from flow cytometric analysis
similar to Figure 1B. Small horizontal bar represents the mean
value of 2-6 mice.
Figure 3. Increase in activated CD4+ T cells in the lung tissue
after transplantation.
Grafted lung tissue from Lewis transplanted with BN lung was
isolated 1, 3 and 5 days after transplantation (1, 3, 5POD). Control
shows the profiles of Lewis left lung. Cells were stained with FITC-
anti-CD4 and biotin-anti-CD25 plus streptavidin-APC, permeabilized
, and stained with PE-anti-Foxp3 Ab. The profiles of CD25 and
Foxp3 expression of CD4+ cells are shown. Numbers indicate the
percentage of cells in each quadrant.
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Effect of CTLA4-Ig on the host T cell response and
allograft rejection
We generated CTLA4-Ig to inhibit lung transplant rejec-
tion (Fig. 4A). First, the efficacy of the CTLA4-Ig which
we prepared was examined in vitro. CTLA4-Ig inhibited MLR
in a dose dependent manner (Fig. 4B). Also, CTLA4-Ig in
hibited the production of cytokines, IL-2, IFN- , TNF- and
IL-10 by CD4+ Lewis T cells in response to BN (Fig. 4C).
Therefore, we examined the effect of CTLA4-Ig and donor-
specific transfusion on the inhibition of acute lung rejection
(Fig. 5). CTLA4-Ig or DST alone did not have significant
effects on lung allograft survival. However, a combination
of the CTLA4-Ig treatment and DST significantly prolonged
lung allograft survival from 5.8±0.96 days to 10.7±0.58 days.
Analysis of host cells infiltrating graft following
CTLA4-Ig and DST treatment
To examine the cellular basis of the effects of CTLA4-Ig
and DST treatment, we have analyzed cells in the grafted
lung tissue. Three days after transplantation cells were pre-
pared from BALF, lung allograft or spleen and analyzed
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Figure 4. Inhibitory effects of CTLA-4-Ig on CD4+ T cell responses in vitro.
(A) Purified CTLA4-Ig was subjected to 12% SDS-PAGE under reducing conditons and was visualized
by Coomassie brilliant blue staining.
(B) Splenic CD4+ T cells (2x105) were purified from Lewis and were cultured with mitomycin C-treated
spleen cells from syngeneic (anti-self) or BN (anti-BN) rat in the presence of 0-10 g/ml of CTLA4-Ig
for 3 days. Proliferation was assed by [3H]-TdR incorporation for 12 hrs at the end of culture.
(C) Lewis CD4+ T cells (3x106) were cultured with mitomycin C-treated spleen cells (3x106) from syngeneic
(self) or BN (BN) rat in the presence and absence of CTLA4-Ig (3 g/ml) for 3 days. RNA was extracted
and the levels of the indicated cytokine mRNA were determined by real-time PCR. * p<0.05.
Figure 5. Effect of CTLA-4-Ig and DST treatment on allograft survival.
Lewis rats received (DST +) or did not receive (DST -) an i.v. in-
jection of BN spleen cells (4x107/rat), and then received BN lung
allograft. The grafted rats received (CTLA4-Ig +) or did not re-
ceive (CTLA4-Ig -) CTLA-4-Ig (500 g/rat) i.v. Rejection of the
lung allograft was judged by radiographic findings. Data were ex-
pressed as mean ± SD. * p<0.05.
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using flow cytometry. We were, however, unable to find
significant differences in the proportions of macrophages,
granulocytes, T and B cells among these three groups of
cells (data not shown). We also analyzed the proportions of
CD4+CD25+ cells in total CD4+ cells. The CD4+CD25+ cells
within the graft 3 days after transplantation were mainly ac-
tivated CD4+ cells and not regulatory T cells (Fig. 3). We
observed a slight reduction of these activated CD4+ cells in
the lung tissue of rats treated with a combination of DST
and CTLA4-Ig, although the differences were not statisti-
cally significant (Fig. 6). We next examined the cytokine
mRNA levels produced in CD4+ and CD8+ cells from these
recipient rats treated with and without DST and CTLA4-Ig.
This type of analysis was made possible by preparing single
cell suspensions of lung-derived cells using the collagenase
digestion method. We examined cells from at least 3 different
rats in each group. However, the variations between these
individual mice in each group were quite large, and we
were unable to obtain significant differences in the cytokine
mRNA levels between these 4 groups of rats (Fig. 7).
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Figure 6. CD4+C25+ T cells in the allograft.
Lewis rats received (+) or did not receive (-) i.v. injection of BN spleen cells (4x107 cells/rat, DST),
and received BN lung allograft. The grafted rats received (+) or did not receive (-) CTLA4-Ig (500
g/rat, CTLA4-Ig) i.v., and were sacrificed on day 3 after transplantation.Cell suspensions were
prepared from BALF, lung tissue and spleen and were stained with FITC-anti-CD4, biotin-anti-
CD25 plus streptavidin-APC, permeabilized and stained with PE-anti-Foxp3 Ab. The graph repre-
sents the proportions of CD4+CD25+ cells within total CD4+ cells as determined by flow cytometric
analysis.
Figure 7. Cytokine mRNA expression in CD4+ and CD8+ cells infiltrating the allograft.
Lewis rats were not treated (1) or treated with CTLA4-Ig (2), DST (3) or both CTLA4-Ig and DST (4), and received BN
left lung transplantation. RNA was extracted from CD4+ and CD8+ cells that were purified from the BALF, left lung tis-
sue and spleen of each rat, and real-time RT-PCR analysis of cytokine gene expression was performed.
Discussion
MHC-mismatched lung allografts are rapidly rejected by
the host immune response. We have applied a collagenase-
digestion method to analyze cells infiltrating grafted lung
tissue. Using this method we were able to analyze single cell
suspensions of cells infiltrating the perivascular, peribronchial
or interstitial spaces of the graft by flow cytometry in addi-
tion to BALF. The grafted lung was filled with host-derived
leukocytes as early as day 1 post transplantation, and the
majority of the initial infiltrating cells were granulocytes.
This initial influx of granulocytes in the lung tissue on post-
operative day 1 may be due to the ischemia-reperfusion in-
jury that coincides with the increase in TNF levels after
lung transplantation15. These granulocytes waned rapidly,
followed by a steady increase in lymphocytes, particularly
T cells, and then by macrophages. The proportion of CD4+
T cells that express CD25 were increased in the graft. The
majority of the increase in CD4+CD25+ cells was due to ac-
tivated CD4+ cells, since the proportions of CD25+foxp3+
cells were not significantly different from those in the spleen.
CTLA4-Ig is a potent immunomodulatory reagent that
has approved clinical applications4, 6, 16,17. In combination with
additional inhibitory reagents such as anti-CD40 Ab, it can
support the long-term acceptance of cardiac, skin or lung
allografts in animal models7, 16. The combination of CTLA4-
Ig and DST was also used for the transplantation of cardiac
allografts resulting in long-term acceptance11. Inhibition of
the interaction between CD80/CD86 and CD28 or CTLA4
by CTLA4-Ig results in profound inhibition of T cell im-
mune responses. Recent studies suggested that a complex
immunoregulatory network is involved in inhibition of im-
mune responses. In addition to the blockade of co-stimulation,
CTLA4-Ig has multiple effects in the regulation of T cell
function6. CTLA4-Ig regulates tryptophan catabolism in dendritic
cells by inducing indoleamine 2,3 dioxygenase (IDO), which
degrades tryptophan, resulting inhibition of T cell activation18.
CTLA4-Ig also has more direct effects on CD4+ foxp3+
regulatory cells. Pretreatment of MHC-mismatched rat renal
allografts with CTLA4-Ig gene transfer resulted in the infil
tration of grafts with foxp3+ T cells with regulatory activity19.
Another local gene therapy study demonstrated a signifi-
cant increase in splenic CD4+CD25+ cells with Treg activity
in rats bearing pancreaticoduodenal grafts that had been
transfected with an adenoviral vector encoding CTLA4-Ig20.
In contrast, CTLA4-Ig has an inhibitory effect on the devel-
opment or homeostasis of CD4+CD25+Foxp3+ Treg cells in
some models such as the NOD mouse21. We have applied
CTLA4-Ig treatment in combination with DST since this
method was previously shown to be effective in the inhibi-
tion of allograft rejection11. However, we observed only a
slight increase in prolongation of graft survival. This result
may have been due to the low dose of CTLA-4-Ig used in
the study due to a limited supply of the protein. Therefore,
we were unable to observe significant differences in the
number and types of cells that infiltrate the lung allograft
with and without CTLA4-Ig treatment. Although we also
examined mRNA expression of cytokine genes in infiltrat-
ing CD4+ and CD8+ T cells, we were unable to observe sig-
nificant effects of the treatment with CTLA4-Ig and DST.
However, our use of collagenase treatment to obtain single
cell preparations from lung allografts provided us with a
method to examine the types and functions of cells that in-
filtrate the transplanted lung and will be useful in future
studies as well.
Taken together, this study showed the infiltration of
waves of donor-derived granulocytes, macrophages and T
lymphocytes into the lung allograft. Also, phenotypical and
functional studies of single cell suspensions from cellular
infiltrates of lung tissue provide us with a useful method for
detailed studies on cells infiltrating lung tissue after graft
transplantation.
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